from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0069c/sdaA

LFCtreatmentdescriptionclass of inhibitor

-0.496

Amikacinug/mL Amikacintranslation

-0.356

Cap5-10ug/mL Capreomycintranslation

-0.916

Rox10-50 ug/mL Roxithromycintranslation

-0.766

SM2-5 ug/mL Streptomycintranslation

-1.329

Tet5-10 ug/mL Tetracyclinetranslation

0.573

Rif0.2-5ug/mL Rifampicintranscription

0.095

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.075

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.565

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.212

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.301

Clofazimine10-13 ug/mL Clofaziminerespiration

1.290

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.159

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.102

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.637

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.984

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.349

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.170

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.237

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.853

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.051

KCN5-20 ug/mL Potassium cyaniderespiration

1.938

NaN30.2-2 mM Sodium aziderespiration

0.448

Nigericin50 uM Nigericinrespiration

1.109

TRC10-150 ug/mL Triclosanrespiration

1.244

TRZ10-25 ug/mL Thioridazinerespiration

-0.432

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.966

menadione6-10 ug/mL Menadionerespiration

-0.244

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.027

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.096

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.127

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.161

NRP_1Non-replicating persistence stage 1dosRassociated

-0.204

Amp0.2mg/mL AmpicillincellWall

0.157

Cephalexin20-100 ug/mL CephalexincellWall

-0.409

Cerulenin0.32-5 ug/mL CerulenincellWall

0.405

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.231

EMB10-20 ug/mL EthambutolcellWall

0.233

Eta12-40 ug/mL EthionamidecellWall

0.602

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.019

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.253

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.500

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.895

BZA0.12 mg/mL BenzamidearomaticAmides

-0.634

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.165

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.418

H2O24 mM hydrogen peroxideDNAdamaging

-0.174

Levo10 ug/mL LevofloxacinDNAdamaging

-0.759

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.722

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.116

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.015

UVUV-irradiationDNAdamaging

0.253

ARP41-4 ug/mL Antitubercular compound ARP4?

0.520

Antimycin12.5-50 ug/mL Antimycin A?

0.157

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.225

PA_110-50 ug/mL Antitubercular compound PA-1?

0.200

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.774

PA8240.2-2 ug/mL PA-824?

0.114

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.190

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.233

Verapamil50 uM Verapamil?

0.169

mercaptoethanol2 mM 2-Mercaptoethanol?

0.699

methoxatin10-20 ug/mL Methoxatin?